A reminder that the three-part webinar series from hivve titled Preparing for Impact in REF 2029 starts next week.
Following the December 2023 announcement from UKRI that REF would be postponed until 2029, this free series is aimed at UK academics who want to get to grips with research impact in general, what the REF requirements are, and how they can begin preparing to ensure maximum success and minimal stress for the 2029 assessment.
The hivve team has been working with institutions since REF 2014 to help prepare for the impact element of the assessment, including the development of Impact Case Studies (ICS), and we are looking forward to sharing our experience with you in the new year.
| 31/01/24
9:15-10am GMT |
Introduction to Research Impact, Impact Case Studies (ICS) and the Research Excellence Framework (REF)
|
| 28/02/24
9:15-10am GMT |
Engaging with Stakeholders and Collecting Data and Evidence
|
| 10/04/24
9:15-10am GMT+1 |
Structuring Compelling Impact Case Studies (ICS) for REF 2029
|
Free research impact training from Fast Track Impact
Free interactive training on impact and UKRI/Horizon 2020 funding bids
Monitoring & Evaluating Impact: Free online training session Monday 28 February 2022
Free workshop: Research Impact in the Arts and Humanities










Opportunities to support our REF preparations
SPROUT Returns: Designing Sustainability in Research Practice – Wednesday 20 May 12-2pm
Innovative Approaches to Doctoral Supervision: Selected Case Studies
3C Event: Research Culture, Community & Canapés-Tuesday 19 May 1-2pm
New chapters published in maternity book on risk
Apply now to take part in the 2026 ESRC Festival of Social Science
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease